CREB1 |
A549 (lung carcinoma) |
1 h with 0.02% Ethanol (Myers) |
Permissive
Robust
|
Homo sapiens |
ENCSR000BRA
|
MA0018.4
|
CREB1 |
A549 (lung carcinoma) |
1 h with 100 nM Dexamethasone (Myers) |
Permissive
|
Homo sapiens |
ENCSR000BRB
|
MA0018.4
|
CREB1 |
A549 (lung carcinoma) |
1 h with 0.02% Ethanol (Myers) |
Permissive
Robust
|
Homo sapiens |
ENCSR000BRC
|
MA0018.4
|
CREB1 |
3T3-L1 (embryonic fibroblasts) |
DMSO |
Permissive
Robust
|
Mus musculus |
GSE33821
...
|
MA0018.4
|
CREB1 |
3T3-L1 (embryonic fibroblasts) |
lactacystin |
Permissive
Robust
|
Mus musculus |
GSE33821
...
|
MA0018.4
|
CREB1 |
liver |
Fasted 24h |
Permissive
Robust
|
Mus musculus |
GSE45674
...
|
MA0018.4
|
CREB1 |
liver |
Fasted 24h, Re-fed 2h |
Permissive
Robust
|
Mus musculus |
GSE45674
...
|
MA0018.4
|
CREB1 |
hepatocytes |
fed 24 h |
Permissive
Robust
|
Mus musculus |
GSE72084
...
|
MA0018.4
|
CREB1 |
hepatocytes |
fasted 24 h |
Permissive
Robust
|
Mus musculus |
GSE72084
...
|
MA0018.4
|
CREB1 |
hepatocytes |
glucagon (10nM) for 1hr |
Permissive
Robust
|
Mus musculus |
GSE72084
...
|
MA0018.4
|
CREB1 |
hepatocytes |
glucagon (10nM) + corticosterone (1.7uM) for 1 hr |
Permissive
Robust
|
Mus musculus |
GSE72084
...
|
MA0018.4
|
CREB1 |
brown preadipocytes |
GR KO |
Permissive
Robust
|
Mus musculus |
GSE76619
...
|
MA0018.4
|
CREB1 |
bone marrow-derived macrophages |
lipid A 0 min |
Permissive
Robust
|
Mus musculus |
GSE99895
...
|
MA0018.4
|
CREB1 |
bone marrow-derived macrophages |
lipid A 15 min |
Permissive
Robust
|
Mus musculus |
GSE99895
...
|
MA0018.4
|
CREB1 |
bone marrow-derived macrophages |
lipid A 30 min |
Permissive
Robust
|
Mus musculus |
GSE99895
...
|
MA0018.4
|
CREB1 |
bone marrow-derived macrophages |
lipid A 60 min |
Permissive
Robust
|
Mus musculus |
GSE99895
...
|
MA0018.4
|
CREB1 |
bone marrow-derived macrophages |
lipid A 120 min |
Permissive
Robust
|
Mus musculus |
GSE99895
...
|
MA0018.4
|
CREB1 |
MDA-MB-134 (invasive lobular breast carcinoma) |
Treatment: DMSO Passage: between 10 and12 CellType: Epithelial ERalpha positive breast cancer cell line |
Permissive
|
Homo sapiens |
GSE109103
...
|
MA0018.4
|
CREB1 |
MDA-MB-134 (invasive lobular breast carcinoma) |
Treatment:100 nM estradiol (E2) for 1hr Passage: between 10 and12 CellType: Epithelial ERalpha positive breast cancer cell line |
Permissive
Robust
|
Homo sapiens |
GSE109103
...
|
MA0018.4
|
CREB1 |
MDA-MB-134 (invasive lobular breast carcinoma) |
Treatment:a cocktail of 10 µM forskolin plus 100 µM 3-isobutyl-1-methylxanthine (FI) for 1hr Passage: between 10 and12 CellType: Epithelial ERalpha positive breast cancer cell line |
Permissive
Robust
|
Homo sapiens |
GSE109103
...
|
MA0018.4
|
CREB1 |
mpkCCD (clone 11) |
Treatment: vehicle treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12 |
Permissive
Robust
|
Mus musculus |
GSE98076
...
|
MA0018.4
|
CREB1 |
mpkCCD (clone 11) |
Treatment: vehicle treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12 |
Permissive
Robust
|
Mus musculus |
GSE98076
...
|
MA0018.4
|
CREB1 |
mpkCCD (clone 11) |
Treatment: vehicle treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12 |
Permissive
Robust
|
Mus musculus |
GSE98076
...
|
MA0018.4
|
CREB1 |
mpkCCD (clone 11) |
Treatment: vehicle treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12 |
Permissive
Robust
|
Mus musculus |
GSE98076
...
|
MA0018.4
|
CREB1 |
mpkCCD (clone 11) |
Treatment: 0.1 nM dDAVP treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12 |
Permissive
|
Mus musculus |
GSE98076
...
|
MA0018.4
|
CREB1 |
mpkCCD (clone 11) |
Treatment: 0.1 nM dDAVP treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12 |
Permissive
Robust
|
Mus musculus |
GSE98076
...
|
MA0018.4
|
CREB1 |
mpkCCD (clone 11) |
Treatment: 0.1 nM dDAVP treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12 |
Permissive
Robust
|
Mus musculus |
GSE98076
...
|
MA0018.4
|
CREB1 |
mpkCCD (clone 11) |
Treatment: 0.1 nM dDAVP treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12 |
Permissive
Robust
|
Mus musculus |
GSE98076
...
|
MA0018.4
|
CREB1 |
MC3T3-E1 (preosteoblasts) |
Treatment: DMSO vehicle for 1 hour; |
Permissive
|
Mus musculus |
GSE62978
...
|
MA0018.4
|
CREB1 |
MC3T3-E1 (preosteoblasts) |
Treatment: 100nM fsk for 1 hour; |
Permissive
|
Mus musculus |
GSE62978
...
|
MA0018.4
|
CREB1 |
WA01 (H1, human embryonic stem cells) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BSN
|
MA0018.4
|
CREB1 |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BSO
|
MA0018.4
|
CREB1 |
GM12878 (female B-cells lymphoblastoid cell line) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BUF
|
MA0018.4
|
CREB1 |
Ishikawa (endometrial adenocarcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BUR
|
MA0018.4
|
CREB1 |
HepG2 (hepatoblastoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BVL
|
MA0018.4
|
CREB1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR620DUQ
|
MA0018.4
|
CREB1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR897JAS
|
MA0018.4
|
CREB1 |
BMDM (bone marrow-derived macrophages) |
|
Permissive
Robust
|
Mus musculus |
GSE64844
...
|
MA0018.4
|
CREB1 |
hepatocytes |
|
Permissive
Robust
|
Mus musculus |
GSE72084
...
|
MA0018.4
|
CREB1 |
brown preadipocytes |
|
Permissive
Robust
|
Mus musculus |
GSE76619
...
|
MA0018.4
|
CREB1 |
brown preadipocytes |
|
Permissive
Robust
|
Mus musculus |
GSE76619
...
|
MA0018.4
|
CREB1 |
LNCaP (prostate carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE63034
|
MA0018.4
|
CREB1 |
HepG2 (hepatoblastoma) |
|
Permissive
|
Homo sapiens |
GSE72082
|
MA0018.4
|
CREB1 |
LNCaP-abl (Prostate carcinoma) |
SHCTR |
Permissive
|
Homo sapiens |
GSE63034
|
MA0018.4
|
CREB1 |
LNCaP-abl (Prostate carcinoma) |
SHFOXA1 |
Permissive
|
Homo sapiens |
GSE63034
|
MA0018.4
|
CREB1 |
KG1 (acute myeloid leukemia) |
DMSO |
Permissive
Robust
|
Homo sapiens |
GSE74928
|
MA0018.4
|
CREB1 |
KG1 (acute myeloid leukemia) |
XX65023 |
Permissive
Robust
|
Homo sapiens |
GSE74928
|
MA0018.4
|
CREB1 |
LNCaP-abl (Prostate carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE63034
|
MA0018.4
|